col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


63 Results       Page 1

 [1] 
American Chemical Society: The Journal of Physical Chemistry Letters
  original article Date Title Authors   All Authors
1 [GO] 2024―Jan―19 Structural Insights into SARS-CoV-2 Nonstructural Protein 1 Interaction with Human Cyclophilin and FKBP1 to Regulate Interferon Production Naveen Vankadari, Debnath Ghosal
2 [GO] 2024―Jan―11 Novel Omicron Variants Enhance Anchored Recognition of TMEM106B: A New Pathway for SARS-CoV-2 Cellular Invasion Xiaoyu Zhao, Feng Gao
3 [GO] 2023―Nov―13 Dynamic Counterion Condensation Model Decodes Functional Dynamics of RNA Pseudoknot in SARS-CoV-2: Control of Ion-Mediated Pierced Lasso Topology Avijit Mainan, Susmita Roy
4 [GO] 2023―Nov―09 Unmasking an Allosteric Binding Site of the Papain-like Protease in SARS-CoV-2: Molecular Dynamics Simulations of Corticosteroids Saroj Kumar Panda, Parth Sarthi Sen Gupta, Shaswata Karmakar, Satyaranjan Biswal, Nimai Charan Mahanandia, Malay Kumar Rana
5 [GO] 2023―Nov―03 SARS-CoV-2 RNA-Dependent RNA Polymerase Follows Asynchronous Translocation Pathway for Viral Transcription and Replication Xiaowei Wang, Tiantian Xu, Yuan Yao, Peter Pak-Hang Cheung, Xin Gao, Lu Zhang
6 [GO] 2023―Oct―18 Data Driven Computational Design and Experimental Validation of Drugs for Accelerated Mitigation of Pandemic-like Scenarios Samrendra K. Singh, Kelsie King, Cole Gannett, Christina Chuong, Soumil Y. Joshi, Charles Plate, et al. (+7)
7 [GO] 2023―Oct―02 Dissecting the Molecular Basis of Host Leucine-Rich Repeat Containing 15 Mediated Interaction with Receptor Binding Domain of SARS-CoV-2 Spike Protein: A Computational Approach Sarbani Mishra, Mansi Sharma, Mahendra Kumar Singh, Sanghamitra Pati, Budheswar Dehury
8 [GO] 2023―Sep―14 Nanoscopic Elucidation of Spontaneous Self-Assembly of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Open Reading Frame 6 (ORF6) Protein Goro Nishide, Keesiang Lim, Maiki Tamura, Akiko Kobayashi, Qingci Zhao, Masaharu Hazawa, et al. (+3)
9 [GO] 2023―Jun―23 Modeling the Interaction of Coronavirus Membrane Phospholipids with Photocatalitically Active Titanium Dioxide Iván Soriano-Díaz, Eros Radicchi, Beatrice Bizzarri, Olivia Bizzarri, Edoardo Mosconi, Muhammad Waqar Ashraf, et al. (+2)
10 [GO] 2023―Apr―06 Quantum Chemical Interaction Analysis between SARS-CoV-2 Main Protease and Ensitrelvir Compared with Its Initial Screening Hit Chiduru Watanabe, Shigenori Tanaka, Yoshio Okiyama, Hitomi Yuki, Tatsuya Ohyama, Kikuko Kamisaka, et al. (+3)
11 [GO] 2023―Mar―27 How SARS-CoV-2 Alters the Regulation of Gene Expression in Infected Cells Emmanuelle Bignon, Stéphanie Grandemange, Elise Dumont, Antonio Monari
12 [GO] 2022―Dec―27 Rapid Detection of SARS-CoV-2 Spike RBD Protein in Body Fluid: Based on Special Calcium Ion-Mediated Gold Nanoparticles Modified by Bromide Ions Fenghai Zhang, Xiaotong Wang, Ting Zhang, Zhe Zhang, Xin Gao, Yang Li
13 [GO] 2022―Nov―10 Moderate Binding between Two SARS-CoV-2 Protein Segments and α-Synuclein Alters Its Toxic Oligomerization Propensity Differently Vince St. Dollente Mesias, Hongni Zhu, Xiao Tang, Xin Dai, Wei Liu, Yusong Guo, Jinqing Huang
14 [GO] 2022―Sep―20 Molecular Mechanism of the Non-Covalent Orally Targeted SARS-CoV-2 Mpro Inhibitor S-217622 and Computational Assessment of Its Effectiveness against Mainstream Variants Danyang Xiong, Xiaoyu Zhao, Song Luo, John Z. H. Zhang, Lili Duan
15 [GO] 2022―Aug―31 S2 Subunit of SARS-CoV-2 Spike Protein Induces Domain Fusion in Natural Pulmonary Surfactant Monolayers Xiaojie Xu, Guangle Li, Bingbing Sun, Yi Y. Zuo
16 [GO] 2022―Aug―05 Identification of Potential ACE2-Derived Peptide Mimetics in SARS-CoV-2 Omicron Variant Therapeutics using Computational Approaches Stanly Paul, Swathi Nadendla, M Elizabeth Sobhia
17 [GO] 2022―Jul―30 Unveiling the “Template-Dependent” Inhibition on the Viral Transcription of SARS-CoV-2 Xueying Luo, Xiaowei Wang, Yuan Yao, Xin Gao, Lu Zhang
18 [GO] 2022―Jun―27 Immune Escape Mechanisms of SARS-CoV-2 Delta and Omicron Variants against Two Monoclonal Antibodies That Received Emergency Use Authorization Danyang Xiong, Xiaoyu Zhao, Song Luo, Yalong Cong, John Z. H. Zhang, Lili Duan
19 [GO] 2022―Jun―21 Primer for Designing Main Protease (Mpro) Inhibitors of SARS-CoV-2 Abhishek Thakur, Gaurav Sharma, Vishnu Nayak Badavath, Venkatesan Jayaprakash, Kenneth M. Merz, Galia Blum, Orlando Acevedo
20 [GO] 2022―Jun―08 Structure of Human TMPRSS2 in Complex with SARS-CoV-2 Spike Glycoprotein and Implications for Potential Therapeutics Naveen Vankadari, Vijayasarathy Ketavarapu, Sasikala Mitnala, Ravikanth Vishnubotla, Duvvur Nageshwar Reddy, Debnath Ghosal
21 [GO] 2022―May―20 Correction to “Elucidation of SARS-Cov-2 Budding Mechanisms through Molecular Dynamics Simulations of M and E Protein Complexes” Logan Thrasher Collins, Tamer Elkholy, Shafat Mubin, David Hill, Ricky Williams, Kayode Ezike, Ankush Singhal
22 [GO] 2022―May―20 Hijacking of Cellular Functions by Severe Acute Respiratory Syndrome Coronavirus-2. Permeabilization and Polarization of the Host Lipid Membrane by Viroporins Emmanuelle Bignon, Marco Marazzi, Antonio Monari
23 [GO] 2022―May―03 2′- and 3′-Ribose Modifications of Nucleotide Analogues Establish the Structural Basis to Inhibit the Viral Replication of SARS-CoV-2 Yongfang Li, Dong Zhang, Xin Gao, Xiaowei Wang, Lu Zhang
24 [GO] 2021―Dec―20 Elucidation of SARS-Cov-2 Budding Mechanisms through Molecular Dynamics Simulations of M and E Protein Complexes Logan Thrasher Collins, Tamer Elkholy, Shafat Mubin, David Hill, Ricky Williams, Kayode Ezike, Ankush Singhal
25 [GO] 2021―Dec―07 Mechanisms of SARS-CoV-2 Evolution Revealing Vaccine-Resistant Mutations in Europe and America Rui Wang, Jiahui Chen, Guo-Wei Wei
26 [GO] 2021―Dec―01 Molecular Basis of SARS-CoV-2 Nsp1-Induced Immune Translational Shutdown as Revealed by All-Atom Simulations Jure Borišek, Angelo Spinello, Alessandra Magistrato
27 [GO] 2021―Nov―12 Interaction Analysis on the SARS-CoV-2 Spike Protein Receptor Binding Domain Using Visualization of the Interfacial Electrostatic Complementarity Takeshi Ishikawa, Hiroki Ozono, Kazuki Akisawa, Ryo Hatada, Koji Okuwaki, Yuji Mochizuki
28 [GO] 2021―Nov―11 Role of Ionizable Lipids in SARS-CoV-2 Vaccines As Revealed by Molecular Dynamics Simulations: From Membrane Structure to Interaction with mRNA Fragments Markéta Paloncýová, Petra Čechová, Martin Šrejber, Petra Kührová, Michal Otyepka
29 [GO] 2021―Oct―17 Structure and Dynamics of RNA Guanine Quadruplexes in SARS-CoV-2 Genome. Original Strategies against Emerging Viruses Tom Miclot, Cécilia Hognon, Emmanuelle Bignon, Alessio Terenzi, Marco Marazzi, Giampaolo Barone, Antonio Monari
30 [GO] 2021―Jul―01 Interfacial Water Many-Body Effects Drive Structural Dynamics and Allosteric Interactions in SARS-CoV-2 Main Protease Dimerization Interface Dina El Ahdab, Louis Lagardère, Théo Jaffrelot Inizan, Fréderic Célerse, Chengwen Liu, Olivier Adjoua, et al. (+6)
31 [GO] 2021―Jul―01 Regulation Mechanism for the Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II Haiyi Chen, Yu Kang, Mojie Duan, Tingjun Hou
32 [GO] 2021―Jun―23 Allosteric Cross-Talk among Spike’s Receptor-Binding Domain Mutations of the SARS-CoV-2 South African Variant Triggers an Effective Hijacking of Human Cell Receptor Angelo Spinello, Andrea Saltalamacchia, Jure Borišek, Alessandra Magistrato
33 [GO] 2021―Jun―10 Conformational Dynamics in the Interaction of SARS-CoV-2 Papain-like Protease with Human Interferon-Stimulated Gene 15 Protein Wellington C. Leite, Kevin L. Weiss, Gwyndalyn Phillips, Qiu Zhang, Shuo Qian, Susan E. Tsutakawa, et al. (+2)
34 [GO] 2021―Jun―04 Machine Learning Reveals the Critical Interactions for SARS-CoV-2 Spike Protein Binding to ACE2 Anna Pavlova, Zijian Zhang, Atanu Acharya, Diane L. Lynch, Yui Tik Pang, Zhongyu Mou, et al. (+3)
35 [GO] 2021―Apr―26 Tuning Proton Transfer Thermodynamics in SARS-CoV-2 Main Protease: Implications for Catalysis and Inhibitor Design Laura Zanetti-Polzi, Micholas Dean Smith, Chris Chipot, James C. Gumbart, Diane L. Lynch, Anna Pavlova, et al. (+2)
36 [GO] 2021―Apr―23 Intermolecular Interaction Analyses on SARS-CoV-2 Spike Protein Receptor Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor-Blocking Antibody/Peptide Using Fragment Molecular Orbital Calculation Kazuki Watanabe, Chiduru Watanabe, Teruki Honma, Yu-Shi Tian, Yusuke Kawashima, Norihito Kawashita, et al. (+2)
37 [GO] 2021―Mar―10 Theoretical Analysis Reveals the Cost and Benefit of Proofreading in Coronavirus Genome Replication Joel D. Mallory, Xian F. Mallory, Anatoly B. Kolomeisky, Oleg A. Igoshin
38 [GO] 2021―Feb―13 Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19 Suresh Gangadevi, Vishnu Nayak Badavath, Abhishek Thakur, Na Yin, Steven De Jonghe, Orlando Acevedo, et al. (+6)
39 [GO] 2021―Feb―02 Retrained Generic Antibodies Can Recognize SARS-CoV-2 Yanxiao Han, Katherine D. McReynolds, Petr Král
40 [GO] 2021―Jan―29 On Drug-Membrane Permeability of Antivirals for SARS-CoV-2 Changjiang Liu, Paolo Elvati, Angela Violi
41 [GO] 2020―Dec―12 Candidate Binding Sites for Allosteric Inhibition of the SARS-CoV-2 Main Protease from the Analysis of Large-Scale Molecular Dynamics Simulations Matteo Carli, Giulia Sormani, Alex Rodriguez, Alessandro Laio
42 [GO] 2020―Dec―05 Computational Insights into the Conformational Accessibility and Binding Strength of SARS-CoV-2 Spike Protein to Human Angiotensin-Converting Enzyme 2 Cheng Peng, Zhengdan Zhu, Yulong Shi, Xiaoyu Wang, Kaijie Mu, Yanqing Yang, et al. (+3)
43 [GO] 2020―Dec―03 Molecular Dynamics Reveals Complex Compensatory Effects of Ionic Strength on the Severe Acute Respiratory Syndrome Coronavirus 2 Spike/Human Angiotensin-Converting Enzyme 2 Interaction Anacleto Silva de Souza, Jose David Rivera, Vitor Medeiros Almeida, Pingju Ge, Robson Francisco de Souza, Chuck Shaker Farah, et al. (+4)
44 [GO] 2020―Nov―23 Theoretical Design of Functionalized Gold Nanoparticles as Antiviral Agents against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Aliyeh Mehranfar, Mohammad Izadyar
45 [GO] 2020―Nov―12 Decoding Asymptomatic COVID-19 Infection and Transmission Rui Wang, Jiahui Chen, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
46 [GO] 2020―Nov―11 Epitope-Based Potential Vaccine Candidate for Humoral and Cell-Mediated Immunity to Combat Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Bratin Kumar Das, Debashree Chakraborty
47 [GO] 2020―Nov―05 In Silico Antibody Mutagenesis for Optimizing Its Binding to Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Binquan Luan, Tien Huynh
48 [GO] 2020―Nov―02 Structure of the SARS-CoV-2 Nsp1/5′-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence Naveen Vankadari, Nandhini Nisha Jeyasankar, Wilma Jerom Lopes
49 [GO] 2020―Oct―26 COSMO-RS-Based Descriptors for the Machine Learning-Enabled Screening of Nucleotide Analogue Drugs against SARS-CoV-2 Sergey Gusarov, Stanislav R. Stoyanov
50 [GO] 2020―Oct―21 Thermodynamics of the Interaction between the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus-2 and the Receptor of Human Angiotensin-Converting Enzyme 2. Effects of Possible Ligands Cristina García-Iriepa, Cécilia Hognon, Antonio Francés-Monerris, Isabel Iriepa, Tom Miclot, Giampaolo Barone, et al. (+2)
51 [GO] 2020―Oct―14 Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase Mark Andrew White, Wei Lin, Xiaodong Cheng
52 [GO] 2020―Sep―04 The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations may Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein Stefano Artin Serapian, Filippo Marchetti, Alice Triveri, Giulia Morra, Massimiliano Meli, Elisabetta Moroni, et al. (+3)
53 [GO] 2020―Aug―25 Alkamides and Piperamides as Potential Antivirals Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Juan Manuel Gutierrez-Villagomez, Tonatiu Campos-García, Jorge Molina Torres, Mercedes G. López, Juan Vázquez-Martínez
54 [GO] 2020―Aug―05 Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies Rohit Batra, Henry Chan, Ganesh Kamath, Rampi Ramprasad, Mathew J. Cherukara, Subramanian K.R.S. Sankaranarayanan
55 [GO] 2020―Aug―03 Dynamic Asymmetry Exposes 2019-nCoV Prefusion Spike Susmita Roy, Akhilesh Jaiswar, Raju Sarkar
56 [GO] 2020―Jul―28 Repurposing Low-Molecular-Weight Drugs Against the Main Protease of Severe Acute Respiratory Syndrome Coronavirus 2 Jia Gao, Liang Zhang, Xiaodan Liu, Fudong Li, Rongsheng Ma, Zhongliang Zhu, et al. (+6)
57 [GO] 2020―Jul―28 Structure of Furin Protease Binding to SARS-CoV-2 Spike Glycoprotein and Implications for Potential Targets and Virulence Naveen Vankadari
58 [GO] 2020―Jun―16 Repositioning of 8565 Existing Drugs for COVID-19 Kaifu Gao, Duc D. Nguyen, Jiahui Chen, Rui Wang, Guowei Wei
59 [GO] 2020―Jun―15 Role of RNA Guanine Quadruplexes in Favoring the Dimerization of SARS Unique Domain in Coronaviruses Cecilia Hognon, Tom Miclot, Cristina Garcia-Iriepa, Antonio Francés-Monerris, Stephanie Grandemange, Alessio Terenzi, et al. (+3)
60 [GO] 2020―Jun―01 Comparing the Binding Interactions in the Receptor Binding Domains of SARS-CoV-2 and SARS-CoV Muhamed Amin, Mariam K. Sorour, Amal Kasry
61 [GO] 2020―May―28 Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atoms Simulations Angelo Spinello, Andrea Saltalamacchia, Alessandra Magistrato
62 [GO] 2020―May―14 In Silico Exploration of Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease Tien Huynh, Haoran Wang, Binquan Luan
63 [GO] 2020―May―11 Novel Coronavirus Polymerase and Nucleotidyl-transferase Structures: Potential to Target New Outbreaks Wenfa Zhang, Preyesh Stephen, Jean-François Thériault, Ruixuan Wang, Sheng-Xiang Lin
 [1] 

63 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec